Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q42984747

about

Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment Treatment of hepatitis C. The 2002 French consensus.The hepatic flaviviridae: summary.Methodological issues in papers on IFN therapy: time for reappraisal.Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C.Treatment of hepatitis C with interferon and ribavirin.Treatment of chronic hepatitis C virus infection.Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy.Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?Developments in the treatment of chronic hepatitis C.Hepatitis C advances in antiviral therapy: what is accepted treatment now?Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.Retreatment of patients with chronic hepatitis C.Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C Improving anti-hepatitis C virus therapy.Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders Management of nonresponsive hepatitis C.Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response.Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response.Hepatitis C Virus Therapy-related Skin Manifestations.Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.Dialysis reduces portal pressure in patients with chronic hepatitis C.Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection.Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C.

P2860

Q28221273-AA47F901-94FB-494F-B7AD-7C83D998105A Q33195269-227ABA75-D5A6-425B-9226-2BEC68D5A802 Q33888790-6BF7EA20-9782-46DE-A772-FF915A89D781 Q33940500-F21340BF-98F5-4CC0-A65A-4B0DAFCE08C7 Q33988105-04E5F3D1-9A71-4CE2-8A47-421971E5249C Q33988146-9E19E8F5-3D11-4E38-9E99-4D48EB0AE491 Q34072137-C69678C9-61A2-4A31-8ADD-DCE7D3A026A4 Q34452230-75B5A564-42F8-4AD4-9C59-98C4ED3A7F4F Q34526034-215205B6-1D89-4627-BDB6-758A36114A91 Q34581499-FD2CE17F-2214-437B-92DE-B61284F13255 Q34619384-E0CC405C-2BB2-466D-B926-220AA2ACE681 Q34700417-9616C00F-2B97-466B-804B-1D1E5E012269 Q34984083-5BA348BC-070A-402A-AF1D-3286D3B7B8B4 Q35552129-6AF39925-024E-4D8C-96AF-0316C6C0999D Q35715916-EA76ED47-7098-4395-A46D-95094AB49C48 Q35800747-296B137F-6A32-4981-8DCF-45EE96E29391 Q36569749-FE748E40-A696-48EF-82E0-95916B53FEC2 Q36933129-E3BD0F51-0144-429A-BEEA-1E10608ECE0D Q37174403-F3B93B75-718B-4BCE-A85B-6AAD29B2CCE0 Q37534731-351A6109-F75B-4B18-A592-A646D650FF18 Q37641036-FE663CC9-4CC4-4653-98C9-9CBC13A4153B Q37727164-47A0E90F-46A8-44E3-A89F-01E3EEF72114 Q38224416-5AF51F06-3CC3-4D4E-AA06-9097757173CF Q39039478-7EF499EF-3BDF-47BE-ABF4-DC99FD70B573 Q40180998-EB8BB0DD-A5DB-4FA5-8FF5-D80CE1F0A536 Q40344794-44F9E979-ABD9-4E1B-8DC0-F2E7C2AE6F35 Q40705785-A1D97375-5DB2-4F3F-A109-6FC68098B417 Q41103902-BECE7FD1-AC2F-4DCA-9512-FCAD5031A127 Q41729153-6A68BC93-B8C8-4142-97AB-499E826D568C Q41840433-5C7AFDDA-D63E-45CD-8F71-030A936FBDF3 Q42245708-5AA5DD2A-C86A-4E7C-A6DF-495CB4B9D8F9 Q43001319-2DEFE1A6-7987-45A1-833B-31DCCE6106DE Q43035368-18A9ACD9-8F8B-480A-850F-2FE37BFE17BD Q45723659-D0875260-474E-4F34-9824-45F15C46702F Q50686838-949E534E-4E90-40AF-B836-C9BF74BE8934

P2860

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q42984747

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Relationship between biochemic ...... atment of chronic hepatitis C.

@en

Relationship between biochemic ...... atment of chronic hepatitis C.

@nl

type

label

Relationship between biochemic ...... atment of chronic hepatitis C.

@en

Relationship between biochemic ...... atment of chronic hepatitis C.

@nl

prefLabel

Relationship between biochemic ...... atment of chronic hepatitis C.

@en

Relationship between biochemic ...... atment of chronic hepatitis C.

@nl

P1433

Q42984747-C7C0B930-37D8-4B5B-9594-817E9A4FAEBA

P1476

Q42984747-AF322BC2-BE18-471C-83F0-D44EEBCBB4B3

P2093

Q42984747-05145A1A-F388-49BD-9B65-FE18606E69A2

Q42984747-0CF87026-ECB6-4769-A907-EE797AD05EC3

Q42984747-2B8C5B9F-5418-41A4-BD2E-A36080EE0D02

Q42984747-2F5F3AC1-69F0-4EFA-A4F6-5F2D21483869

Q42984747-4B9585B5-DC01-444B-8C5C-1BA2AEC7CEBF

Q42984747-5E6416FE-A4FA-43A0-BC0B-F352A1B5FBEC

Q42984747-A0F5ED1E-6E19-4E0D-8F79-67F9E667242D

Q42984747-A60F51E0-EB2C-4D3E-B30B-2141B3FDEAF2

Q42984747-BE21524A-8FDC-473B-B636-C16C6EDB6E5B

Q42984747-BFD9D0CC-8681-4D22-A248-69D8C35D4523

P304

Q42984747-C82DDEE7-B4D9-400C-AA9B-63C614BA6F28

P31

Q42984747-3135517C-6A16-42E0-A96A-9335AF28699B

P356

Q42984747-24972840-90D7-4F06-8F98-ECD010EBBD47

P407

Q42984747-AA5D2F77-B1BC-43FD-9D18-70836B61A86D

P433

Q42984747-95F8B65D-EC12-4685-9046-888C41CB3D60

P478

Q42984747-B7D7044E-E136-4CDF-85CF-F92BCC936B78

P577

Q42984747-8945FA2E-EEAB-42CF-B07E-FE5881138FAF

P5875

Q42984747-3B73794A-F763-41A6-8903-077C394DBB6D

P698

Q42984747-6D85EF68-0273-4D77-81B0-FCA1CD84B8AC

P921

Q42984747-AF638A7D-9102-49D7-BB50-522A5614E131

P356

P1433

P1476

Relationship between biochemic ...... atment of chronic hepatitis C.

@en

P2093

A Ferreira-Gonzalez

http://www.w3.org/2001/XMLSchema#string

A J Sanyal

http://www.w3.org/2001/XMLSchema#string

A Koshy

http://www.w3.org/2001/XMLSchema#string

A S Mills

http://www.w3.org/2001/XMLSchema#string

C M Hofmann

http://www.w3.org/2001/XMLSchema#string

C T Garrett

http://www.w3.org/2001/XMLSchema#string

E B Thompson

http://www.w3.org/2001/XMLSchema#string

M J Contos

http://www.w3.org/2001/XMLSchema#string

M L Shiffman

http://www.w3.org/2001/XMLSchema#string

V A Luketic

http://www.w3.org/2001/XMLSchema#string

P304

780-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.510260335

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13917114

http://www.w3.org/2001/XMLSchema#string

P698

9303513

http://www.w3.org/2001/XMLSchema#string

P921